Skip to main content

Please select
your location below

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

By selecting the International view, you verify that you reside outside of the USA and you wish to view DiaSorin Molecular’s International Product Information. This material is intended for International (non-USA) site visitors only.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professionaloperators.

注意 - ATTENTION

目前仅LUMINEX LTG部分的内容采用中文表达，所有其它内容依旧提供英文版本

Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Chinese.

Document repository

Dialog

Product list

Catalog

Need more information?

Contact us

Direct links

Your search results

Infectious diseases

LIAISON® XL / LIAISON® XS

LIAISON® MeMed BV®

The first high-throughput, fully automated CLIA assay to quickly differentiate between bacterial and viral infections in a single procedure. Combining host-immune protein measurements it overcomes the diagnostic difficulties of traditional testing methods, making LIAISON® MeMed BV® ideal for patients with suspected acute infections.
Discover more
LIAISON® XL / LIAISON® XS

LIAISON® BRAHMS MR-proADMTM

The first high-quality quantitative CLIA assay that assesses disease severity in patients with a suspected infection by detecting Mid-regional pro-adrenomedullin (MR-proADMTM) via a single test. It is ideal for patients with suspected acute infections at ED and ICU.
Discover more
LIAISON® XL / LIAISON® XS

LIAISON® BRAHMS PCT® II Gen

LIAISON® BRAHMS PCT® II Gen is a CLIA assay for the quantitative determination of procalcitonin in human serum and plasma specimens. The assay is intended for use, in conjunction with other laboratory findings and clinical assessments, to aid in the risk analysis for critically ill patients regarding the progression of relevant bacterial infections.
Discover more

Related products

LIAISON® XL
LIAISON® XS

LIAISON® BRAHMS PCT® II Gen

LIAISON® BRAHMS PCT® II Gen is a CLIA assay for the quantitative determination of procalcitonin in human serum and plasma specimens. The assay is intended for use, in conjunction with other laboratory findings and clinical assessments, to aid in the risk analysis for critically ill patients regarding the progression of relevant bacterial infections.

Learn More
LIAISON® XL
LIAISON® XS

LIAISON® BRAHMS MR-proADMTM

The first high-quality quantitative CLIA assay that assesses disease severity in patients with a suspected infection by detecting Mid-regional pro-adrenomedullin (MR-proADMTM) via a single test. It is ideal for patients with suspected acute infections at ED and ICU.

Learn More
LIAISON® XL
LIAISON® XS

LIAISON® BRAHMS PCT® II Gen

LIAISON® BRAHMS PCT® II Gen is a CLIA assay for the quantitative determination of procalcitonin in human serum and plasma specimens. The assay is intended for use, in conjunction with other laboratory findings and clinical assessments, to aid in the risk analysis for critically ill patients regarding the progression of relevant bacterial infections.

Learn More
LIAISON® XL
LIAISON® XS

LIAISON® MeMed BV®

The first high-throughput, fully automated CLIA assay to quickly differentiate between bacterial and viral infections in a single procedure. Combining host-immune protein measurements it overcomes the diagnostic difficulties of traditional testing methods, making LIAISON® MeMed BV® ideal for patients with suspected acute infections.

Learn More
LIAISON® XL
LIAISON® XS

LIAISON® QuantiFERON® TB-Gold Plus

LIAISON® QuantiFERON TB-Gold Plus is an IGRA based-test that drastically improves tuberculosis testing compared to traditional tests.

Learn More
LIAISON® XL

LIAISON® Bordetella pertussis Diagnostic Solution

The first complete solution with optimal diagnostic performance for Bordetella pertussis diagnosis 

  • LIAISON® Bordetella pertussis Toxin IgA
  • LIAISON® Bordetella pertussis Toxin IgG
Learn More
LIAISON® XL
LIAISON® XS

LIAISON® Mycoplasma pneumoniae Diagnostic Solution

Differential serological diagnosis of Mycoplasma Pneumoniae: a crucial step for effective patient management.

Learn More
LIAISON® XL
LIAISON® XS

LIAISON® MeMed BV®

The first high-throughput, fully automated CLIA assay to quickly differentiate between bacterial and viral infections in a single procedure. Combining host-immune protein measurements it overcomes the diagnostic difficulties of traditional testing methods, making LIAISON® MeMed BV® ideal for patients with suspected acute infections.

Learn More
LIAISON® XL
LIAISON® XS

LIAISON® QuantiFERON® TB-Gold Plus

LIAISON® QuantiFERON TB-Gold Plus is an IGRA based-test that drastically improves tuberculosis testing compared to traditional tests.

Learn More
LIAISON® XL

LIAISON® Bordetella pertussis Diagnostic Solution

The first complete solution with optimal diagnostic performance for Bordetella pertussis diagnosis 

  • LIAISON® Bordetella pertussis Toxin IgA
  • LIAISON® Bordetella pertussis Toxin IgG
Learn More
LIAISON® XL
LIAISON® XS

LIAISON® Mycoplasma pneumoniae Diagnostic Solution

Differential serological diagnosis of Mycoplasma Pneumoniae: a crucial step for effective patient management.

Learn More
LIAISON® XL
LIAISON® XS

LIAISON® BRAHMS MR-proADMTM

The first high-quality quantitative CLIA assay that assesses disease severity in patients with a suspected infection by detecting Mid-regional pro-adrenomedullin (MR-proADMTM) via a single test. It is ideal for patients with suspected acute infections at ED and ICU.

Learn More
Load more

Didn't find what you were looking for?

Search again